|
0 Comments
Our latest manuscript: "Synergistic combinations and repurposed antibiotics active against the pandrug-resistant Klebsiella pneumoniae Nevada strain." Antimicrobial Agents and Chemotherapy early release identifies:
Highly synergistic activity of several antimicrobial combinations. Low apramycin and spectinomycin MIC values. CDC previously reported that none of 26 antimicrobials they tested were active against the Nevada strain. That made the strain until now pandrug-resistant. Links to several news articles about this pandrug-resistant strain:: The Atlantic. NPR, NBC, PBS. Forbes "3 Drug Combinations Appear Effective Against C auris" by Jared Kaltwasser discussed work presented by Thea Brennan-Krohn at ASM Microbe 2019.
Kate, KP, and Thea presented posters at ASM Microbe 2019. Thea not shown.
BIDMC press release on poster presented by postdoctoral fellow, Thea-Brennan Krohn, at the ASM Microbe Meeting in San Francisco this past weekend!
https://www.bidmc.org/about-bidmc/news/2019/06/combination-of-drugs-may-combat-deadly-drugresistant-fungus "Using the inkjet technology to dispense uniform samples of C. auris into each of the 96 wells in a standard lab testing plate, Brennan-Krohn tested 10 combinations against 10 strains of C. auris, a painstaking process that would have taken at least 50 hours if done by hand. It took less than two hours in total using the inkjet dispenser for Brennan-Krohn to find three novel combinations of antifungal and antibacterial drugs that demonstrated activity against this insidious new pathogen." First author KP Smith. ICCB Screening Center plays pivotal role. More details to follow!
 There is a very fancy drawing of a single cell life form on the slide undoubtedly being compromised by a combination of antimicrobial therapeutics applied in Thea, Liam, and Sarah's experiments!
|
Kirby Lab Blog Categories
All
Archives
November 2019
|
RSS Feed